Car-T Cell Therapy: Current Advances and Future Research Possibilities

Journal of Scientific Research in Medical and Biological Sciences

View Publication Info
 
 
Field Value
 
Title Car-T Cell Therapy: Current Advances and Future Research Possibilities
 
Creator Ahmed, Manal Mohamed Elsayed
 
Subject CAR-T cell therapy, hematological tumor, Solid tumors, Immunotherapy
 
Description Purpose: The aim is to review the current advances in designing safer and more efficient CAR-T cells and discuss the future research possibilities for the treatment of both hematological malignancies and solid tumors.
Study Design: An extensive review was carried out on the basic structure of CARS, current advances to design safer and more efficient CAR-T cells, and future research possibilities for the treatment of both hematological malignancies and solid tumors.
Results: Encouragement of chimeric antigen receptor-T (CAR-T) cell therapy as one of adoptive immunotherapy is increasingly important in recent years. Its preparation is based on the genetic modification of individual T cells. The innovation of the functional intracellular signaling domain is a critical part of the genetically modified T cells and requires a long journey of development that has resulted in several improvements in the safety and effectiveness of CAR-T cells. CAR-T cell therapy can be modified rapidly and has great and strong application potential according to a large number of global clinical trials. This article briefly describes the basic structure and design of CARs and discusses current trends in the development of safer and more efficient CAR-T cells for the treatment of both hematological and solid malignancies and looks forward to future research possibilities.
Conclusion: It is concluded that conclude that the prospect of this technology lies in CAR-T cell engineering which can overcome aggressive TMEs and recruiting an endogenous tumor response. The final task for researchers in this field is to carry out clinical trials and secure the funding needed to complete their clinical trials. This immunotherapy continues to progress and more records of successful malignancy eradication occur.
 
Publisher Baynoon Centre for Studies and Development (BCSD)
 
Date 2021-05-26
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
 
Identifier http://bcsdjournals.com/index.php/jsrmbs/article/view/234
10.47631/jsrmbs.v2i2.234
 
Source Journal of Scientific Research in Medical and Biological Sciences; Vol. 2 No. 2 (2021): Journal of Scientific Research in Medical and Biological Sciences; 86-116
2709-1511
2709-0159
 
Language eng
 
Relation http://bcsdjournals.com/index.php/jsrmbs/article/view/234/139
 
Rights Copyright (c) 2021 Journal of Scientific Research in Medical and Biological Sciences
https://creativecommons.org/licenses/by/4.0
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library